True Wealth Design, LLC Ovid Therapeutics Inc. Call Options Transaction History
True Wealth Design, LLC
- $263 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OVID
# of Institutions
83Shares Held
39.8MCall Options Held
1.7KPut Options Held
100-
Rubric Capital Management LP New York, NY5.32MShares$1.65 Million0.05% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$1.24 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$1.19 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.11MShares$963,7220.0% of portfolio
-
Madison Avenue Partners, LP New York, NY2.47MShares$764,3430.1% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $21.8M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...